H.L. Ormond & Company’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$210K Sell
1,736
-9
-0.5% -$1.16K 0.34% 88
2022
Q2
$224K Buy
1,745
+50
+3% +$6.55K 0.36% 85
2022
Q1
$232K Hold
1,695
0.28% 95
2021
Q4
$226K Buy
+1,695
New +$225K 0.26% 98

Other funds holding XLV

H.L. Ormond & Company's XLV Position: Q3 2022 in Review

H.L. Ormond & Company reduced its State Street Health Care Select Sector SPDR ETF (XLV) stake by 0.52% in Q3 2022, selling an estimated $1.16K and leaving 1,736 shares worth $210K. The position accounts for 0.34% of the portfolio, ranked #88.

H.L. Ormond & Company first reported a position in XLV in Q4 2021 and has held it in 4 quarters since. The position peaked at $232K in Q1 2022. 1,422 funds tracked by Wall St. Rank hold XLV as of Q3 2022.

  • H.L. Ormond & Company held 1,736 shares of State Street Health Care Select Sector SPDR ETF worth $210K as of Q3 2022.
  • H.L. Ormond & Company sold 9 State Street Health Care Select Sector SPDR ETF shares in Q3 2022, an estimated $1.16K.
  • State Street Health Care Select Sector SPDR ETF made up 0.34% of H.L. Ormond & Company's portfolio in Q3 2022, its #88 holding.
  • H.L. Ormond & Company first reported a position in State Street Health Care Select Sector SPDR ETF in Q4 2021 and has held it in 4 quarters since.
  • H.L. Ormond & Company's State Street Health Care Select Sector SPDR ETF position peaked at $232K in Q1 2022.
  • 1,422 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q3 2022.

Based on H.L. Ormond & Company's 13F filing for Q3 2022, filed 14 Nov 2022.